Acute Effects of Electronic Cigarette Inhalation on the Vasculature and the Conducting Airways.


Journal

Cardiovascular toxicology
ISSN: 1559-0259
Titre abrégé: Cardiovasc Toxicol
Pays: United States
ID NLM: 101135818

Informations de publication

Date de publication:
10 2019
Historique:
pubmed: 10 4 2019
medline: 12 5 2020
entrez: 10 4 2019
Statut: ppublish

Résumé

The use of electronic cigarettes has increased exponentially since its introduction onto the global market in 2006. However, short- and long-term health effects remain largely unknown due to the novelty of this product. The present study examines the acute effects of e-cigarette aerosol inhalation, with and without nicotine, on vascular and pulmonary function in healthy volunteers. Seventeen healthy subjects inhaled electronic cigarette aerosol with and without nicotine on two separate occasions in a double-blinded crossover fashion. Blood pressure, heart rate, and arterial stiffness measured by pulse wave velocity and pulse wave analysis were assessed at baseline, and then at 0 h, 2 h, and 4 h following exposure. Dynamic spirometry and impulse oscillometry were measured following vascular assessments at these time points, as well as at 6 h following exposure. e-Cigarette aerosol with nicotine caused a significant increase in heart rate and arterial stiffness. Furthermore, e-cigarette aerosol-containing nicotine caused a sudden increase in flow resistance as measured by impulse oscillometry, indicating obstruction of the conducting airways. Both aerosols caused an increase in blood pressure. The present study indicates that inhaled e-cigarette aerosol with nicotine has an acute impact on vascular and pulmonary function. Thus, chronic usage may lead to long-term adverse health effects. Further investigation is warranted.

Identifiants

pubmed: 30963443
doi: 10.1007/s12012-019-09516-x
pii: 10.1007/s12012-019-09516-x
pmc: PMC6746878
doi:

Substances chimiques

Aerosols 0
Nicotinic Agonists 0
Nicotine 6M3C89ZY6R

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

441-450

Références

Occup Environ Med. 2001 Oct;58(10):649-55
pubmed: 11555686
Eur Respir J. 2003 Dec;22(6):1026-41
pubmed: 14680096
Eur Respir J. 2005 Aug;26(2):319-38
pubmed: 16055882
Am J Respir Crit Care Med. 2006 Jul 15;174(2):127-33
pubmed: 16645173
Circ J. 2006 Oct;70(10):1231-9
pubmed: 16998252
Nicotine Tob Res. 2008 Dec;10(12):1773-82
pubmed: 19023828
Part Fibre Toxicol. 2009 Mar 13;6:7
pubmed: 19284640
Circulation. 2010 Feb 2;121(4):505-11
pubmed: 20083680
Atherosclerosis. 2011 Apr;215(2):281-3
pubmed: 21345436
Eur J Cardiovasc Prev Rehabil. 2011 Dec;18(6):775-89
pubmed: 21450600
Nicotine Tob Res. 2011 Jul;13(7):573-8
pubmed: 21454913
Chest. 2012 Jun;141(6):1400-1406
pubmed: 22194587
Eur J Epidemiol. 2012 Oct;27(10):771-9
pubmed: 22722951
Lancet. 2012 Dec 15;380(9859):2224-60
pubmed: 23245609
Inhal Toxicol. 2013 Feb;25(2):91-101
pubmed: 23363041
Int J Hyg Environ Health. 2014 Jul;217(6):628-37
pubmed: 24373737
J Intern Med. 2014 Jul;276(1):87-95
pubmed: 24548296
Int J Environ Res Public Health. 2014 May 08;11(5):4965-77
pubmed: 24814944
Circulation. 2014 May 13;129(19):1972-86
pubmed: 24821826
Circulation. 2014 Jul 22;130(4):325-32
pubmed: 24958793
Am J Respir Crit Care Med. 2014 Sep 15;190(6):611-8
pubmed: 25006874
PLoS One. 2016 Mar 04;11(3):e0151022
pubmed: 26942764
Chest. 2016 Sep;150(3):606-12
pubmed: 27108682
Thorax. 2016 Dec;71(12):1119-1129
pubmed: 27558745
Nicotine Tob Res. 2017 Feb;19(2):160-167
pubmed: 27613896
Atherosclerosis. 2016 Dec;255:179-185
pubmed: 27693003
Tob Control. 2017 Mar;26(e1):e23-e28
pubmed: 27729564
J Intern Med. 2017 Apr;281(4):398-406
pubmed: 28164394
J Am Heart Assoc. 2017 Sep 20;6(9):null
pubmed: 28931527
Nicotine Tob Res. 2019 Aug 19;21(9):1228-1238
pubmed: 29868926
Vasc Med. 2018 Oct;23(5):419-425
pubmed: 29985113
Sci Rep. 2018 Jul 10;8(1):10378
pubmed: 29991814
J Hypertens. 2019 Jan;37(1):154-166
pubmed: 30063637
Clin Pharmacol Ther. 1988 Jul;44(1):23-8
pubmed: 3391001
J Appl Physiol (1985). 1994 Jun;76(6):2420-7
pubmed: 7928866
N Engl J Med. 1996 Dec 12;335(24):1792-8
pubmed: 8943160

Auteurs

Lukasz Antoniewicz (L)

Division of Internal Medicine, Department of Clinical Sciences, Karolinska Institutet, Danderyd University Hospital, 182 88, Stockholm, Sweden. lukasz.antoniewicz@ki.se.

Amelie Brynedal (A)

Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.

Linnea Hedman (L)

Department of Public Health and Clinical Medicine, Occupational and Environmental Medicine, The OLIN Unit, Umeå University, Umeå, Sweden.
Division of Nursing, Department of Health Science, Luleå University of Technology, Luleå, Sweden.

Magnus Lundbäck (M)

Division of Cardiovascular Medicine, Department of Clinical Sciences, Karolinska Institutet, Danderyd University Hospital, Stockholm, Sweden.

Jenny A Bosson (JA)

Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH